Browse corpus88

doctype: guideline subtype: mdr_tb

Showing 76–88 of 88 documents

Sorted by hybrid relevance (keyword + semantic via RRF)

GuidelineMDR-TB2019-03
WHO consolidated guidelines on drug-resistant tuberculosis treatment: annexes 3-9
World Health Organization
GuidelineMDR-TB2001-12
Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for dots-plus
World Health Organization. Communicable Diseases Cluster
GuidelineMDR-TB

World Health Organization

GuidelineMDR-TB2000-12

Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB) / writing committee: Scientific Panel of the WHO Working Group on DOTS-Plus for MDR-TB

WHO Working Group on DOTS-Plus for MDR-TB. Scientific Panel, World Health Organization. Communicable Diseases Cluster

GuidelineMDR-TB2022-10

360° Drug-Susceptibility Testing Quality Assurance Assessment Dashboard: 360° DST QAAD: a practical tool based on the latest WHO recommendations

World Health Organization. Regional Office for Europe

The 360° DST Quality Assurance Assessment Dashboard (QAAD) is a digital tool designed to provide a thorough and standardized assessment of all the procedures involved in producing the results required for the efficient and effective treatment of drug-resistant TB comprising both …

Browse corpus88

WHO consolidated guidelines on drug-resistant tuberculosis treatment: annexes 3-9

Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for dots-plus

Guidelines for surveillance of drug resistance in tuberculosis

WHO consolidated guidelines on tuberculosis: module 1: prevention: infection prevention and control: web annex D: systematic reviews

WHO consolidated guidelines on tuberculosis: module 1: prevention: infection prevention and control: web annex A: methods and expert panels

WHO consolidated guidelines on tuberculosis: module 1: prevention: infection prevention and control: web annex B: GRADE evidence summary tables

WHO consolidated guidelines on tuberculosis: module 1: prevention: infection prevention and control: web annex C: GRADE evidence-to-decision tables

Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (2016), 28 - 29 June 2016, Geneva, Switzerland

Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB) / writing committee: Scientific Panel of the WHO Working Group on DOTS-Plus for MDR-TB

360° Drug-Susceptibility Testing Quality Assurance Assessment Dashboard: 360° DST QAAD: a practical tool based on the latest WHO recommendations

Guidelines for workplace TB control activities : the contribution of workplace TB control activities to TB control in the community / Dermot Maher ... [et al.] ; with Phyllis Gabriel, Sophie Kisting, Pierre-Yves Norval

Report of a WHO expert consultation on dosing to enable implementation of treatment recommendations in the WHO consolidated guidelines on the management of TB in children and adolescents

Ethambutol efficacy and toxicity : literature review and recommendations for daily and intermittent dosage in children